- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,423GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,423GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,423GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,423GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,423GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,423GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,423GBP
- Report
- January 2026
- 180 Pages
Global
From €3972EUR$4,500USD£3,430GBP
- Report
- May 2025
- 115 Pages
Global
From €4193EUR$4,750USD£3,621GBP
- Report
- May 2025
- 154 Pages
Global
From €4193EUR$4,750USD£3,621GBP
- Report
- July 2025
- 350 Pages
Global
From €4368EUR$4,949USD£3,772GBP
- Report
- July 2025
- 350 Pages
Global
From €4368EUR$4,949USD£3,772GBP
- Report
- June 2025
- 400 Pages
Global
From €4368EUR$4,949USD£3,772GBP
- Report
- August 2025
- 149 Pages
Global
From €3487EUR$3,950USD£3,011GBP
- Report
- November 2025
- 160 Pages
Global
From €2964EUR$3,358USD£2,559GBP
€3487EUR$3,950USD£3,011GBP
- Report
- November 2025
- 160 Pages
Global
From €2964EUR$3,358USD£2,559GBP
€3487EUR$3,950USD£3,011GBP
- Report
- November 2025
- 160 Pages
Global
From €2964EUR$3,358USD£2,559GBP
€3487EUR$3,950USD£3,011GBP
- Report
- October 2025
- 160 Pages
Global
From €2964EUR$3,358USD£2,559GBP
€3487EUR$3,950USD£3,011GBP
- Report
- February 2026
- 82 Pages
Global
From €3500EUR$4,248USD£3,128GBP
- Report
- July 2025
- 132 Pages
Global
From €4281EUR$4,850USD£3,697GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more